Astatine-211 based PSMA-inhibitors for targeted alpha-therapy of prostate cancer

被引：0
|
作者：
Poulie, Christian [1 ]
El Fakiri, Mohamed [2 ]
Ayada, Nawal [2 ]
Gamzov, Teodor [1 ]
Muller, Marius [1 ]
Jensen, Holger [3 ]
Lindegren, Sture [4 ]
Jensen, Andreas [1 ,5 ]
Kjaer, Andreas
Eder, Ann-Christin [2 ]
Eder, Matthias [6 ]
Herth, Matthias [1 ]
机构：
[1] Univ Copenhagen, Copenhagen, Denmark
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[4] Univ Gothenburg, Gothenburg, Sweden
[5] Tech Univ Denmark, Lyngby, Denmark
[6] Univ Med Ctr, Freiburg, Germany
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2022年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-017
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [1] Production and assessment of astatine-211 for targeted alpha therapy
    Crawford, J.
    Beckham, W.
    Jirasek, A.
    Ruth, T.
    MEDICAL PHYSICS, 2012, 39 (07) : 4627 - 4627
  • [2] An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma
    Vaidyanathan, Ganesan
    Mease, Ronnie
    Affleck, Donna
    Chen, Ying
    Welsh, Philip
    Hens, Marc
    Pomper, Martin
    Zalutsky, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [3] New technologies for astatine-211 targeted alpha therapy research
    Crawford, Jason
    Yang, Hua
    Schaffer, Paul
    Ruth, Thomas
    MEDICAL PHYSICS, 2016, 43 (08) : 4928 - 4928
  • [4] Astatine-211 for PSMA-targeted α-radiation therapy of micrometastatic prostate cancer: a sustainable approach towards precision oncology
    Chakravarty, Rubel
    Lan, Xiaoli
    Chakraborty, Sudipta
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (07) : 1844 - 1847
  • [5] Astatine-211 for PSMA-targeted α-radiation therapy of micrometastatic prostate cancer: a sustainable approach towards precision oncology
    Rubel Chakravarty
    Xiaoli Lan
    Sudipta Chakraborty
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1844 - 1847
  • [6] NOAR COST Action: Advancing Targeted Alpha Therapy with Astatine-211 for Cancer Treatment
    Janevik-Ivanovska, E.
    Gestin, J.
    Aneheim, E.
    Lindegren, S.
    Gaschet, J.
    Palm, S.
    Niculae, D.
    Bouziotis, P.
    Pruzynski, M.
    Kolenc, P.
    Jensen, A. I.
    Abrunhosa, A.
    Navarro, L.
    Jensen, H.
    Mikolajczak, R.
    Herth, M. M.
    Konijnenberg, M.
    Guerard, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S825 - S825
  • [7] ASTATINE-211 IN CANCER-THERAPY
    COBB, LM
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 819 - 819
  • [8] Targeted alpha-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine
    Chakravarty, Rubel
    Siamof, Cerise M.
    Dash, Ashutosh
    Cai, Weibo
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 8 (04): : 247 - 267
  • [9] Evaluation of new targeted alpha therapy using astatine (211At) labeled PSMA5 for prostate cancer
    Watabe, Tadashi
    Toyoshima, Atsushi
    Fukase, Koichi
    CANCER SCIENCE, 2023, 114 : 119 - 119
  • [10] Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211
    Timperanza, Chiara
    Lindegren, Sture
    Aneheim, Emma
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S259 - S260
12345